Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cahaba Pharmaceuticals
AddedFeb 16, 2024
UpdatedJun 18, 2026
Cahaba Pharmaceuticals

Cahaba Pharmaceuticals

Angel

Cahaba Pharmaceuticals: Innovating oncology therapeutics and supportive care for cancer patients since 2008.

HQ
Birmingham, AL, US
Founded
2008
Overview
Compare
Fundraising
Employees

Cahaba Pharmaceuticals, LLC is a biotech company dedicated to developing oncology therapeutics and supportive care products for cancer patients. Their product lineup includes 1uracil topical ointment for treating hand-foot syndrome and triciribine phosphate monohydrate, which inhibits AKT to combat cancer cell growth and resistance to treatments. Founded in 2008, Cahaba focuses on innovative solutions to improve cancer care.

Cahaba Pharmaceuticals has made significant strides in oncology, with its products addressing critical needs in cancer treatment. Their innovative therapies have the potential to enhance patient outcomes and quality of life. The company's impact is underscored by its commitment to advancing cancer care through targeted and effective treatments.

Cahaba Pharmaceuticals - Similar Companies

CBA Pharma logo

CBA Pharma

cbapharma.com

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Tigris Pharmaceuticals logo

Tigris Pharmaceuticals

tigrispharma.com

Akanocure Pharmaceuticals logo

Akanocure Pharmaceuticals

akanocure.com

Panacea Pharmaceuticals logo

Panacea Pharmaceuticals

Cairn Therapeutics logo

Cairn Therapeutics

Innocrin Pharmaceuticals logo

Innocrin Pharmaceuticals

innocrinpharma.com

Hylapharm logo

Hylapharm

hylapharm.com

Cage Pharma logo

Cage Pharma

cagephar.ma

Karyopharm Therapeutics logo

Karyopharm Therapeutics

karyopharm.com

BioNumerik Pharmaceuticals logo

BioNumerik Pharmaceuticals

Abby Med logo

Abby Med

Trio Pharmaceuticals logo

Trio Pharmaceuticals

Advanced Cancer Therapeutics logo

Advanced Cancer Therapeutics

Oncoholdings logo

Oncoholdings

Cahaba Pharmaceuticals - Quick Facts

Who are Cahaba Pharmaceuticals' competitors?

Companies similar to Cahaba Pharmaceuticals include CBA Pharma, Novita Pharmaceuticals, Tigris Pharmaceuticals and Akanocure Pharmaceuticals.

When was Cahaba Pharmaceuticals founded?

Cahaba Pharmaceuticals was founded in 2008.

Where is Cahaba Pharmaceuticals' headquarters located?

Cahaba Pharmaceuticals' headquarters is located in Birmingham, AL, US.

When was Cahaba Pharmaceuticals' last funding round?

Cahaba Pharmaceuticals' most recent funding round was for $205k (USD) in January 2013.

How much has Cahaba Pharmaceuticals raised to-date?

As of Jan 18, 2013, Cahaba Pharmaceuticals has raised a total of $1.8M (USD).

How many employees does Cahaba Pharmaceuticals have?

Cahaba Pharmaceuticals has 5 employees as of Feb 5, 2024.

Cahaba Pharmaceuticals - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatments
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified